Press Releases

Origin-ASI (www.origin-asi.com) offers a full range of clinical trials services for the pharmaceutical, biotechnology and medical device industries worldwide. The joint venture combines Origin's expertise in clinical project management and regulatory affairs with ASI's capabilities in advanced data management, biostatistics, e-trials solutions, Oracle Clinical support, medical writing and health communications.

"We are pleased to partner with Origin in this exciting new joint venture," said ASI President and CEO Donald A. Holzworth. "Origin, which operates predominately in Europe, offers exceptional complementary capabilities to ours. In addition, Origin enables ASI to broaden its reach into Europe, and likewise, ASI gives Origin new opportunities in the United States. By combining our core competencies and market experience, we offer clients a greater depth of clinical trials expertise around the globe."

Origin Managing Director Steve Smith said, "This joint venture is a continuation of partnering strategies designed to bring additional near-term business expansion opportunities to both ASI and Origin. By tapping into the resources of Origin-ASI, clients can achieve a unified and integrated clinical project, which will be particularly beneficial for studies conducted both in the U.S. and in Europe."

Smith noted that the arrangement between ASI and Origin is not simply a strategic partnership, but rather the formation of a new legal entity committed to integrating the companies' expertise in a way that helps clients successfully guide their products to market in the shortest time. "This is a very exciting new venture enabling two like-minded companies with specific expertise to provide a complete global clinical trials service," he said.

Analytical Sciences, Inc. (ASI)

Founded in 1983, Analytical Sciences, Inc. (ASI) is an award-winning human health research organization dedicated to enhancing human health through innovative science, technology and knowledge solutions. Headquartered in Durham, N.C., ASI conducts research and provides technical and professional services to help government and industry clients identify and solve problems affecting human health. Through its Clinical Research arm, ASI offers a full range of human health research capabilities for the pharmaceutical, biotechnology and medical device industries. The company excels in offering efficient and reliable data management services with expertise in CRF design, database design and development, query management and data quality audits, delivered with innovative Web-based technology. ASI employs today's most advanced data management tools, such as Oracle Clinical™ and SAS^®, to help clients achieve study results that are accurate and consistent with study goals. One of the cornerstones of ASI is its highly experienced biostatistic group, which offers biostatistic services for all phases of pre-clinical studies, clinical trials and pharmaceutical outcomes research. ASI also offers services in Oracle Clinical consulting, coding, medical writing and health communications. For more information, visit the company's Web site at www.constellagroup.com.

Origin Pharmaceutical Services Limited

Formed in 1999 and headquartered near Oxford, UK, Origin is a CRO that provides a flexible range of product development services with core competencies in strategic planning, regulatory affairs and clinical trials. In addition to managing Phase I-IV studies, Origin delivers a range of expert regulatory services. Its in-house staff is able to help with clinical trial applications, MAAs, NDA to MAA conversions, variations and renewals, product registrations (MRP and centralized), regulatory authority liaison and data evaluation. Origin also provides an ad-hoc advice service called "regs-on-line," which gives clients instant access to regulatory expertise. The company has more than 40 clients based in Europe, Japan and the United States. For more information, visit the company's Web site at www.originpharm.com.